Skip to main content

Series C Pharmaceutical Companies

Explore 54 pharmaceutical startups that raised series c funding. Access verified founder contact information and fundraising data.

Total Companies
54
Total Funding
$2.3B
Avg Funding
$92.2M
Cities
17

Export 54 Series C Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Mateo, United States
$75.0M
raised

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

Sep 2026
Series C

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$140.0M
raised

Basecamp Research is a biotechnology company that uses artificial intelligence and biological data to develop therapeutics.

Sep 2026
Series C

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States
$123.0M
raised

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

Sep 2026
Series C

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$120.0M
raised

AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.

Aug 2026
Series C

Founder Contacts

41,000+ verified contacts

Boston, United States
$70.0M
raised

Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Jul 2026
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 54 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$100.0M
raised

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

Feb 2026
Series C

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$24.0M
raised

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

Jan 2026
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$12.0M
raised

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Jan 2026
Series C

Founder Contacts

41,000+ verified contacts

San Diego, United States
$115.0M
raised

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Nov 2025
Series C

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$157.0M
raised

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 54 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Munich, Germany
$400.6M
raised

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

San Diego, United States
$5.4M
raised

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Sep 2025
Series C

Founder Contacts

41,000+ verified contacts

San Diego, United States
$60.1M
raised

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Aug 2025
Series C

Founder Contacts

41,000+ verified contacts

Richmond, United States
$37.0M
raised

Phlow supplies affordable, quality, essential medicines through U.S.-based advanced manufacturing processes.

Jul 2025
Series C

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$25.7M
raised

PolyActiva develops products that enable drug release from medical devices.

May 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 54 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$30.0M
raised

Arine uses AI to optimize medication therapy, improving patient outcomes and reducing healthcare costs for payers and providers.

May 2025
Series C

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$115.0M
raised

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Apr 2025
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$92.0M
raised

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$207.5M
raised

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Seongnam, South Korea
$13.6M
raised

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Dec 2024
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 54 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Montreal, Canada
$53.0M
raised

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

Nov 2024
Series C

Founder Contacts

41,000+ verified contacts

Valencia, United States
$115.0M
raised

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

Oct 2024
Series C

Founder Contacts

41,000+ verified contacts

Schlieren, Switzerland
$11.0M
raised

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Sep 2024
Series C

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Jun 2024
Series C

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$182.0M
raised

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

May 2024
Series C

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 54 companies

Ready to Connect with Series C Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 54 series c pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked